Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD
Clinical trial NCT03004417 · COMPLETED
Trial details
- NCT number
- NCT03004417
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2017-12-28
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.